Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l-Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β-l-Ribofuranosyl-1H-Benzimidazole

Although a number of antiviral drugs inhibit replication of Epstein-Barr virus (EBV) in cell culture, and acyclovir (ACV) suppresses replication in vivo, currently available drugs have not proven effective for treatment of EBV-associated diseases other than oral hairy leukoplakia. Benzimidazole ribo...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Zacny, Valerie L., Gershburg, Eduard, Davis, Michelle G., Biron, Karen K., Pagano, Joseph S.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1999
Soggetti:	Vaccines and Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC104252/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10438815/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.9.7271-7277.1999
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!